In humans, ADAR1 is mutated in a rare autosomal‐dominant disease, such as Aicardi–Goutières syndrome (AGS), which affects its catalytic activity, leading to a total and uncontrolled activation of its downstream intracellular dsRNA sensor pathway [15, 16]. This evidence concerns the gene ADAR and Aicardi-Goutieres syndrome.